Association of systemic immune-inflammatory index with in-stent restenosis in patients with and without diabetes mellitus
BackgroundSystemic inflammation plays a vital role in the pathogenesis and prognosis of cardiovascular disease (CAD). The systemic immune-inflammation index (SII) has been developed as a cost-effective and practical predictor for CAD outcomes. This study aimed to determine the association between th...
Saved in:
Main Authors: | Xunwei Deng, Qiaoting Deng, Qunji Zhang, Jingyuan Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1419314/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-inflammatory coupled anti-angiogenic airway stent effectively suppresses tracheal in-stents restenosis
by: Yanan Zhao, et al.
Published: (2025-01-01) -
Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01) -
Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01) -
Comparison of Gensini score and SYNTAX score for predicting in-stent restenosis in patients with coronary artery disease and drug-eluting stent implantation
by: Min-Tao Gai, et al.
Published: (2025-01-01) -
The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
by: Kazunori Horie, MD, et al.
Published: (2025-01-01)